bluebird bio
Stock Forecast, Prediction & Price Target
bluebird bio Financial Estimates
bluebird bio Revenue Estimates
bluebird bio EBITDA Estimates
bluebird bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $3.66M N/A | $3.59M -1.77% | $29.49M 720.04% | Avg: $269.92M Low: $269.92M High: $269.92M avg. 815.08% | Avg: $348.31M Low: $348.31M High: $348.31M avg. 29.04% | Avg: $387.01M Low: $387.01M High: $387.01M avg. 11.11% | Avg: $452.15M Low: $452.15M High: $452.15M avg. 16.83% |
Net Income
% change YoY
| $-562.63M N/A | $-266.57M 52.61% | $-211.91M 20.50% | Avg: $-88.27M Low: $-88.27M High: $-88.27M avg. 58.34% | Avg: $-52.50M Low: $-52.50M High: $-52.50M avg. 40.52% | Avg: $-27.50M Low: $-27.50M High: $-27.50M avg. 47.61% | Avg: $-4.32M Low: $-4.32M High: $-4.32M avg. 84.28% |
EBITDA
% change YoY
| $-539.30M N/A | $-277.21M 48.59% | $-167.16M 39.69% | Avg: $-269.92M Low: $-269.92M High: $-269.92M avg. -61.47% | Avg: $-348.31M Low: $-348.31M High: $-348.31M avg. -29.04% | Avg: $-387.01M Low: $-387.01M High: $-387.01M avg. -11.11% | Avg: $-452.15M Low: $-452.15M High: $-452.15M avg. -16.83% |
EPS
% change YoY
| -$8.16 N/A | -$3.39 58.45% | -$1.93 43.06% | Avg: -$1.12 Low: -$1.12 High: -$1.12 avg. 41.79% | Avg: -$0.67 Low: -$0.67 High: -$0.67 avg. 40.52% | Avg: -$0.35 Low: -$0.35 High: -$0.35 avg. 47.61% | Avg: -$0.06 Low: -$0.06 High: -$0.06 avg. 84.28% |
Operating Expenses
% change YoY
| $529.91M N/A | $275.67M -47.97% | $240.23M -12.85% | Avg: $5.71B Low: $5.71B High: $5.71B avg. 2277.69% | Avg: $7.37B Low: $7.37B High: $7.37B avg. 29.04% | Avg: $8.18B Low: $8.18B High: $8.18B avg. 11.11% | Avg: $9.56B Low: $9.56B High: $9.56B avg. 16.83% |
FAQ
What is bluebird bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 57.69% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -88.27M, average is -88.27M and high is -88.27M.
What is bluebird bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 218.01% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $269.92M, average is $269.92M and high is $269.92M.
What is bluebird bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 53.55% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.12, average is -$1.12 and high is $-1.12.